Epidemiology of and diagnostic strategies for toxoplasmosis

Clinical Microbiology Reviews

Volumn 25, Issue 2, 2012, Pages 264-296

  Robert Gangneux, Florence ^a,b   Dardé, Marie Laure ^c,d,e  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE LIMOGES   (France)

^e LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; COTRIMOXAZOLE; FOLINIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MALOPRIM; PENTAMIDINE; PROTOZOAL PROTEIN; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; STAT3 PROTEIN; STAT6 PROTEIN; SULFADIAZINE; SULFADOXINE; TUMOR NECROSIS FACTOR ALPHA;

AGGLUTINATION TEST; AMNION FLUID ANALYSIS; ANIMAL PARASITOSIS; ANTIBODY RESPONSE; AQUEOUS HUMOR; ASEXUAL REPRODUCTION; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BRADYZOITE; CELL CULTURE; CELL INVASION; CELL MEMBRANE; CEREBROSPINAL FLUID EXAMINATION; CHEMOPROPHYLAXIS; CHORIORETINITIS; CLINICAL TRIAL (TOPIC); CONGENITAL INFECTION; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CYST (RESTING STAGE); DISEASE CONTROL; ECHOGRAPHY; ENCEPHALITIS; ENTOMOPATHOGENY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INJURY; FLUORESCENT ANTIBODY TECHNIQUE; FOOD CONTAMINATION; FOOD POISONING; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEARING IMPAIRMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST CELL; HOST PARASITE INTERACTION; HUMAN; HYDROCEPHALUS; HYGIENE; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INTESTINE CELL; LIFE CYCLE; LIVESTOCK; MEAT; MENINGOENCEPHALITIS; MEROZOITE; META ANALYSIS (TOPIC); MICROSATELLITE MARKER; MULTICENTER STUDY (TOPIC); MYOCARDITIS; NATURAL KILLER CELL; NONHUMAN; OOCYST; ORGAN TRANSPLANTATION; PARACENTESIS; PARASITE LOAD; PARASITE TRANSMISSION; PARASITE VIRULENCE; PERINATAL PERIOD; PLACENTAL TRANSFER; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POLYMERASE CHAIN REACTION; POLYMYOSITIS; POSTOPERATIVE INFECTION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK FACTOR; SCHIZONT; SCREENING; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SOIL POLLUTION; SYSTEMATIC REVIEW (TOPIC); TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; UVEITIS; VERTICAL TRANSMISSION; WATER CONTAMINATION; WESTERN BLOTTING;

HUMANS; PREVALENCE; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 84859523382     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.05013-11     Document Type: Review

References (343)

1. Abbasi M, et al. 2003. Infection of placental trophoblasts by Toxoplasma gondii. J. Infect. Dis. 188:608-616.
2. Abgrall S, Rabaud C, Costagliola D. 2001. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin. Infect. Dis. 33:1747-1755.
3. Afonso E, Thulliez P, Gilot-Fromont E. 2010. Local meteorological conditions, dynamics of seroconversion to Toxoplasma gondii in cats (Felis catus) and oocyst burden in a rural environment. Epidemiol. Infect. 138:1105-1113.
4. Afonso E, Thulliez P, Gilot-Fromont E. 2006. Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). Int. J. Parasitol. 36:1373-1382.
5. Afonso E, Thulliez P, Pontier D, Gilot-Fromont E. 2007. Toxoplasmosis in prey species and consequences for prevalence in feral cats: not all prey species are equal. Parasitology 134:1963-1971.
6. Agence Française de Sécurité Sanitaire des Aliments. 2005. Toxoplasmose: état des connaissances et évaluation du risque lié a l'alimentation. Rapport du groupe de travail Toxoplasma gondii de l'Afssa. AFSSA, Paris, France. http://www.anses.fr/Documents/MIC-Ra-Toxoplasmose.pdf.
7. Ajioka JW, Soldati D (ed). 2007. Toxoplasma: molecular and cellular biology. Horizon Biosciences, Norfolk, United Kingdom.
8. Ajzenberg D, et al. 2004. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int. J. Parasitol. 34:1185-1196.
9. Ajzenberg D, Banuls AL, Tibayrenc M, Dardé ML. 2002. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int. J. Parasitol. 32:27-38.
10. Ajzenberg D, et al. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689.
11. Ajzenberg D, Collinet F, Mercier A, Vignoles P, Darde ML. 2010. Genotyping of Toxoplasma gondii isolates with 15 microsatellite markers in a single multiplex PCR assay. J. Clin. Microbiol. 48:4641-4645.
12. Ajzenberg D, Dumetre A, Darde ML. 2005. Multiplex PCR for typing strains of Toxoplasma gondii. J. Clin. Microbiol. 43:1940-1943.
13. Ajzenberg D, et al. 2009. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J. Infect. Dis. 199:1155-1167.
14. Albat B, Serre I, Pratlong F, Thevenet A, Baldet P. 1992. Opportunistic toxoplasmosis in a case of heart transplantation. Agressologie 33(Spec No 2):103-104. (In French.)
15. Alfonso Y, et al. 2009. Molecular diagnosis of Toxoplasma gondii infection in cerebrospinal fluid from AIDS patients. Cerebrospinal Fluid Res. 6:2.
16. Andrade GM, et al. 2010. Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J. Pediatr. (Rio J.) 86:85-88.
17. Aramini JJ, et al. 1999. Potential contamination of drinking water with Toxoplasma gondii oocysts. Epidemiol. Infect. 122:305-315.
18. Arnold SJ, Kinney MC, McCormick MS, Dummer S, Scott MA. 1997. Disseminated toxoplasmosis. Unusual presentations in the immunocompromised host. Arch. Pathol. Lab. Med. 121:869-873.
19. Aubert D, et al. 2010. Molecular and biological characteristics of Toxoplasma gondii isolates from wildlife in France. Vet. Parasitol. 171: 346-349.
20. Baden LR, et al. 2003. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation 75:339-343.
21. Bahia-Oliveira LM, et al. 2003. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg. Infect. Dis. 9:55-62.
22. Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. 2010. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch. Ophthalmol. 128:28-32.
23. Baran DA, et al. 2006. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers. J. Heart Lung Transplant. 25:1380-1382.
24. Baril L, et al. 1999. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand. J. Infect. Dis. 31:305-309.
25. Barragan A, Hitziger N. 2008. Transepithelial migration by Toxoplasma. Subcell. Biochem. 47:198-207.
26. Barragan A, Sibley LD. 2002. Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J. Exp. Med. 195:1625-1633.
27. Bastien P. 2002. Molecular diagnosis of toxoplasmosis. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl 1):S205-S215.
28. Bastien P, Jumas-Bilak E, Varlet-Marie E, Marty P. 2007. Three years of multi-laboratory external quality control for the molecular detection of Toxoplasma gondii in amniotic fluid in France. Clin. Microbiol. Infect. 13:430-433.
29. Beghetto E, et al. 2003. Use of an immunoglobulin Gavidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J. Clin. Microbiol. 41:5414-5418.
30. Benenson MW, Takafuji ET, Lemon SM, Greenup RL, Sulzer AJ. 1982. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N. Engl. J. Med. 307:666-669.
31. Beraud G, et al. 2009. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006. Am. J. Trop. Med. Hyg. 80:583-587.
32. Berger F, Goulet V, Le Strat Y, Desenclos JC. 2009. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev. Epidemiol. Sante Publique 57:241-248.
33. Berrebi A, et al. 2010. Long-term outcome of children with congenital toxoplasmosis. Am. J. Obstet. Gynecol. 203:552 e551-556.
34. Bessieres MH, et al. 2009. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 104:389-392.
35. Bessieres MH, et al. 2001. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur. J. Obstet. Gynecol. Reprod. Biol. 94:37-45.
36. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY. 2008. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J. Immunol. 181:8485-8491.
37. Black MW, Boothroyd JC. 2000. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 64:607-623.
38. Blanc-Jouvan M, et al. 1996. Chorioretinitis following liver transplantation: detection of Toxoplasma gondii in aqueous humor. Clin. Infect. Dis. 22:184-185.
39. Bliss SK, Gavrilescu LC, Alcaraz A, Denkers EY. 2001. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect. Immun. 69:4898-4905.
40. Botterel F, et al. 2002. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J. Clin. Microbiol. 40:1648-1650.
41. Bowie WR, et al. 1997. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet 350:173-177.
42. Boyer K, et al. 2011. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 53:1081-1089.
43. Boyer KM, et al. 2005. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am. J. Obstet. Gynecol. 192:564-571.
44. Boyle JP, et al. 2006. Just one cross appears capable of dramatically altering the population biology of a eukaryotic pathogen like Toxoplasma gondii. Proc. Natl. Acad. Sci. U. S. A. 103:10514-10519.
45. Bretagne S, et al. 2000. Prospective study of Toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl. Infect. Dis. 2:127-132.
46. Brezin AP, et al. 2003. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am. J. Ophthalmol. 135: 779-784.
47. Burg JL, Grover CM, Pouletty P, Boothroyd JC. 1989. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27:1787-1792.
48. Burnett AJ, et al. 1998. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105:1032-1037.
49. Campbell AL, et al. 2006. First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantation. Transplantation 81:408-417.
50. Carme B, et al. 2002. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J. Clin. Microbiol. 40:4037-4044.
51. Carruthers V, Boothroyd JC. 2007. Pulling together: an integrated model of Toxoplasma cell invasion. Curr. Opin. Microbiol. 10:83-89.
52. Cavailles P, et al. 2006. The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-dependent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 103:744-749.
53. Cavattoni I, et al. 2010. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny. Leuk. Lymphoma 51:1530-1535.
54. Cazenave J, Cheyrou A, Blouin P, Johnson AM, Begueret J. 1991. Use of polymerase chain reaction to detect Toxoplasma. J. Clin. Pathol. 44: 1037.
55. Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F. 2010. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J. Clin. Microbiol. 48:41-45.
56. Chemla C, Villena I, Trenque T, Pinon JM. 2005. Prenatal treatment of congenital toxoplasmosis. Presse Med. 34:1719. (In French.)
57. Chiquet C, Fleury J, Blanc-Jouvan M, Wallon M, Boibieux A. 2000. Acquired ocular toxoplasmosis (panuveitis) after liver transplantation. J. Fr. Ophtalmol. 23:375-379. (In French.)
58. Cingolani A, et al. 1996. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J. Med. Microbiol. 45:472-476.
59. Colombo FA, et al. 2005. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J. Clin. Microbiol. 43:5044-5047.
60. Combe CL, et al. 2006. Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite. Proc. Natl. Acad. Sci. U. S. A. 103:6635-6640.
61. Conrad PA, et al. 2005. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int. J. Parasitol. 35:1155-1168.
62. Cook AJ, et al. 2000. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 321:142-147.
63. Cornu C, et al. 2009. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Euro Surveill. 14:21-25.
64. Correia CC, Melo HR, Costa VM. 2010. Influence of neurotoxoplasmosis characteristics on real-time PCR sensitivity among AIDS patients in Brazil. Trans. R. Soc. Trop. Med. Hyg. 104:24-28.
65. Cortina-Borja M, et al. 2010. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 7:pii_e1000351.
66. Cristina N, Liaud MF, Santoro F, Oury B, Ambroise-Thomas P. 1991. A family of repeated DNA sequences in Toxoplasma gondii: cloning, sequence analysis, and use in strain characterization. Exp. Parasitol. 73: 73-81.
67. Dabritz HA, et al. 2007. Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the environmental oocyst burden. J. Am. Vet. Med. Assoc. 231:1676-1684.
68. Dabritz HA, et al. 2008. Risk factors for Toxoplasma gondii infection in wild rodents from central coastal California and a review of T. gondii prevalence in rodents. J. Parasitol. 94:675-683.
69. Darde ML. 2008. Toxoplasma gondii, "new" genotypes and virulence. Parasite 15:366-371.
70. Darde ML, Bouteille B, Pestre-Alexandre M. 1992. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol. 78:786-794.
71. Darde ML, Bouteille B, Pestre-Alexandre M. 1988. Isoenzymic characterization of seven strains of Toxoplasma gondii by isoelectrofocusing in polyacrylamide gels. Am. J. Trop. Med. Hyg. 39:551-558.
72. Delair E, et al. 2011. Clinical manifestations of ocular toxoplasmosis. Ocul. Immunol. Inflamm. 19:91-102.
73. Delair E, et al. 2008. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am. J. Ophthalmol. 146:851-855.
74. De-la-Torre A, Gonzalez G, Diaz-Ramirez J, Gomez-Marin JE. 2007. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am. J. Ophthalmol. 143:354-356.
75. Delhaes L, et al. 2010. Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review. Prenat. Diagn. 30:902-905.
76. Demar M, et al. 2007. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin. Infect. Dis. 45:e88-e95.
77. De Moura L, et al. 2006. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg. Infect. Dis. 12:326-329.
78. Denkers EY, Butcher BA, Del Rio L, Kim L. 2004. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol. Rev. 201:191-205.
79. Derouin F, et al. 1992. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin. Infect. Dis. 15:267-270.
80. Derouin F, et al. 1986. Toxoplasma infection after human allogeneic bone marrow transplantation: clinical and serological study of 80 patients. Bone Marrow Transplant. 1:67-73.
81. Derouin F, et al. 1996. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS 10:1521-1527.
82. Derouin F, Pelloux H. 2008. Prevention of toxoplasmosis in transplant patients. Clin. Microbiol. Infect. 14:1089-1101.
83. De Salvador-Guillouet F, et al. 2006. Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man. J. Infect. 53:e47-e50.
84. Desmonts G, Couvreur J. 1974. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N. Engl. J. Med. 290:1110-1116.
85. Desmonts G, Couvreur J, Thulliez P. 1990. Congenital toxoplasmosis. 5 cases of mother-to-child transmission of pre-pregnancy infection. Presse Med. 19:1445-1449. (In French.)
86. Desmonts G, et al. 1985. Prenatal diagnosis of congenital toxoplasmosis. Lancet i:500-504.
87. De Sousa S, et al. 2006. Biologic and molecular characterization of Toxoplasma gondii isolates from pigs from Portugal. Vet. Parasitol. 135: 133-136.
88. De Thoisy B, Demar M, Aznar C, Carme B. 2003. Ecologic correlates of Toxoplasma gondii exposure in free-ranging neotropical mammals. J. Wildl. Dis. 39:456-459.
89. Doesch AO, et al. 2010. Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation. Transpl. Int. 23:382-389.
90. Dos Santos TR, et al. 2010. Detection of Toxoplasma gondii oocysts in environmental samples from public schools. Vet. Parasitol. 171:53-57.
91. Dubey JP. 1998. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 28:1019-1024.
92. Dubey JP. 1988. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am. J. Vet. Res. 49:910-913.
93. Dubey JP. 1998. Refinement of pepsin digestion method for isolation of Toxoplasma gondii from infected tissues. Vet. Parasitol. 74:75-77.
94. Dubey JP. 2010. Toxoplasmosis of animals and humans, 2nd ed. CRC Press, Boca Raton, FL.
95. Dubey JP, Ferreira L, Martins J, Jones J. 2011. Sporulation and survival of Toxoplasma gondii oocysts in different types of commercial cat litters. J. Parasitol. 97:751-754.
96. Dubey JP, Frenkel JK. 1972. Cyst-induced toxoplasmosis in cats. J. Protozool. 19:155-177.
97. Dubey JP, et al. 2002. High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in Massachusetts. J. Parasitol. 88:1234-1238.
98. Dubey JP, et al. 2005. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J. Parasitol. 91:1082-1093.
99. Dubey JP, Huong LT, Sundar N, Su C. 2007. Genetic characterization of Toxoplasma gondii isolates in dogs from Vietnam suggests their South American origin. Vet. Parasitol. 146:347-351.
100. Dubey JP, Jones JL. 2008. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38:1257-1278.
101. Dubey JP, Kotula AW, Sharar A, Andrews CD, Lindsay DS. 1990. Effect of high temperature on infectivity of Toxoplasma gondii tissue cysts in pork. J. Parasitol. 76:201-204.
102. Dubey JP, Lindsay DS, Speer CA. 1998. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11:267-299.
103. Dubey JP, et al. 2006. Characterization of Toxoplasma gondii isolates in free-range chickens from Chile, South America. Vet. Parasitol. 140:76-82.
104. Dubey JP, et al. 2008. Isolation and genetic characterization of Toxoplasma gondii from raccoons (Procyon lotor), cats (Felis domesticus), striped skunk (Mephitis mephitis), black bear (Ursus americanus), and cougar (Puma concolor) from Canada. J. Parasitol. 94:42-45.
105. Dubey JP, et al. 2007. Prevalence of Toxoplasma gondii in dogs from Sri Lanka and genetic characterization of the parasite isolates. Vet. Parasitol. 146:341-346.
106. Dubey JP, et al. 2011. High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA. Int. J. Parasitol. 41:827-833.
107. Dubey JP, et al. 2008. High prevalence and abundant atypical genotypes of Toxoplasma gondii isolated from lambs destined for human consumption in the USA. Int. J. Parasitol. 38:999-1006.
108. Dubey JP, Thulliez P. 1993. Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am. J. Vet. Res. 54:270-273.
109. Dubremetz JF. 2007. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction. Cell. Microbiol. 9:841-848.
110. Dumetre A, Darde ML. 2007. Detection of Toxoplasma gondii in water by an immunomagnetic separation method targeting the sporocysts. Parasitol. Res. 101:989-996.
111. Dumetre A, Darde ML. 2003. How to detect Toxoplasma gondii oocysts in environmental samples? FEMS Microbiol. Rev. 27:651-661.
112. Dumetre A, et al. 2008. Effects of ozone and ultraviolet radiation treatments on the infectivity of Toxoplasma gondii oocysts. Vet. Parasitol. 153:209-213.
113. Duncanson P, Terry RS, Smith JE, Hide G. 2001. High levels of congenital transmission of Toxoplasma gondii in a commercial sheep flock. Int. J. Parasitol. 31:1699-1703.
114. Dunn D, et al. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829-1833.
115. Duszynski DW, Lee Couch L, Upton SJ. August 2000, posting date. Coccidia (Eimeriidae) of Canidae and Felidae. http://biology.unm.edu/biology/coccidia/carniv1.html.
116. Elbez-Rubinstein A, et al. 2009. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J. Infect. Dis. 199:280-285.
117. El Hajj H, et al. 2007. ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog. 3:e14.
118. Ertug S, Okyay P, Turkmen M, Yuksel H. 2005. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 5:66.
119. Eskild A, Magnus P. 2001. Little evidence of effective prenatal treatment against congenital toxoplasmosis-the implications for testing in pregnancy. Int. J. Epidemiol. 30:1314-1315.
120. Esmerini PO, Gennari SM, Pena HF. 2010. Analysis of marine bivalve shellfish from the fish market in Santos city, Sao Paulo state, Brazil, for Toxoplasma gondii. Vet. Parasitol. 170:8-13.
121. European Food Safety Authority. 2007. Surveillance and monitoring of Toxoplasma in humans, food and animals: scientific opinion of the Panel on Biological Hazards. EFSA J. 583:1-64. http://www.efsa.europa.eu/fr/efsajournal/pub/583.htm.
122. Fardeau C, et al. 2002. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am. J. Ophthalmol. 134:196-203.
123. Fekkar A, et al. 2011. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J. Clin. Microbiol. 49:1513-1517.
124. Fekkar A, et al. 2008. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-timePCRusing aqueous humor samples for diagnosis of ocular toxoplasmosis. J. Clin. Microbiol. 46: 1965-1967.
125. Ferguson DJ. 2002. Toxoplasma gondii and sex: essential or optional extra? Trends Parasitol. 18:355-359.
126. Ferguson DJ. 2004. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int. J. Parasitol. 34:347-360.
127. Fernandez-Sabe N, et al. 2011. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin. Infect. Dis. 54:355-361.
128. Foudrinier F, et al. 2003. Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis. J. Clin. Microbiol. 41:1681-1686.
129. Foulon W, et al. 1999. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am. J. Obstet. Gynecol. 181:843-847.
130. Foulon W, et al. 1999. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am. J. Obstet. Gynecol. 180:410-415.
131. Franck J, Garin YJ, Dumon H. 2008. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-Toxoplasma antibody detection. J. Clin. Microbiol. 46:2334-2338.
132. Franzen C, et al. 1997. Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients. J. Clin. Microbiol. 35:2639-2641.
133. Freeman K, et al. 2008. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 121:e1215-e1222.
134. French AR, Holroyd EB, Yang L, Kim S, Yokoyama WM. 2006. IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation. Cytokine 35:229-234.
135. Frenkel JK, Dubey JP, Miller NL. 1970. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 167:893-896.
136. Fricker-Hidalgo H, et al. 2007. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 26:845-846.
137. Fricker-Hidalgo H, et al. 2005. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation. Transpl. Infect. Dis. 7:38-40.
138. Fricker-Hidalgo H, et al. 2009. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin. Infect. Dis. 48:e9-e15.
139. Fricker-Hidalgo H, et al. 1998. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures. Placenta 19:545-549.
140. Fricker-Hidalgo H, et al. 2006. New Vidas assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera. Diagn. Microbiol. Infect. Dis. 56: 167-172.
141. Gallino A, et al. 1996. Toxoplasmosis in heart transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 15:389-393.
142. Garbino J, et al. 2005. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Med. Wkly. 135:587-593.
143. Garin JP, Pellerat J, Maillard, Woehrle-Hezez R. 1968. Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women. Presse Med. 76:2266. (In French.)
144. Garweg JG, Garweg SD, Flueckiger F, Jacquier P, Boehnke M. 2004. Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis. J. Clin. Microbiol. 42:4593-4598.
145. Garweg JG, Jacquier P, Boehnke M. 2000. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J. Clin. Microbiol. 38:996-1001.
146. Gavinet MF, et al. 1997. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J. Clin. Microbiol. 35:1276-1277.
147. Gilbert R, et al. 2003. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110:112-120.
148. Gilbert RE, et al. 2008. Ocular sequelae of digenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2:e277.
149. Gilbert RE, et al. 2001. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int. J. Epidemiol. 30:1303-1308.
150. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. 1995. Incidence of acute symptomatic Toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310:1037-1040.
151. Gilbert RE, et al. 2007. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J. Med. Screen. 14:8-13.
152. Giraldo M, et al. 2002. Immunoglobulin M (IgM)-glycoinositolphospholipid enzyme-linked immunosorbent assay: an immunoenzymatic assay for discrimination between patients with acute toxoplasmosis and those with persistent parasite-specific IgM antibodies. J. Clin. Microbiol. 40:1400-1405.
153. Gollub EL, Leroy V, Gilbert R, Chene G, Wallon M. 2008. Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 136:137-145.
154. Gomez-Marin JE, et al. 2011. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl. Trop. Dis. 5:e1195.
155. Gordon SM, et al. 1993. Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients. Diagn. Cytopathol. 9:650-654.
156. Gourishankar S, et al. 2008. The use of donor and recipient screening for Toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 85:980-985.
157. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. 2004. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol. Infect. 132:541-548.
158. Gras L, et al. 2005. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 94:1721-1731.
159. Gratzl R, et al. 2002. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 21:12-16.
160. Grigg ME, Suzuki Y. 2003. Sexual recombination and clonal evolution of virulence in Toxoplasma. Microbes Infect. 5:685-690.
161. Guerina NG, et al. 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N. Engl. J. Med. 330: 1858-1863.
162. Guy EC, Joynson DH. 1995. Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood. J. Infect. Dis. 172:319-322.
163. Hakim M, Esmore D, Wallwork J, English TA, Wreghitt T. 1986. Toxoplasmosis in cardiac transplantation. Br. Med. J. (Clin. Res. Ed.) 292:1108.
164. Halos L, et al. 2010. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. Int. J. Parasitol. 40:193-200.
165. Havelaar AH, Kemmeren JM, Kortbeek LM. 2007. Disease burden of congenital toxoplasmosis. Clin. Infect. Dis. 44:1467-1474.
166. Hennequin C, et al. 1997. Congenital toxoplasmosis acquired from an immune woman. Pediatr. Infect. Dis. J. 16:75-77.
167. Hermanns B, et al. 2001. Fulminant toxoplasmosis in a heart transplant recipient. Pathol. Res. Pract. 197:211-215.
168. Herwaldt BL. 2001. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev. 14:659-688.
169. Heukelbach J, et al. 2007. Waterborne toxoplasmosis, northeastern Brazil. Emerg. Infect. Dis. 13:287-289.
170. Hill D, et al. 2011. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J. Parasitol. 97:328-337.
171. Hill DE, et al. 2006. Effects of time and temperature on the viability of Toxoplasma gondii tissue cysts in enhanced pork loin. J. Food Prot. 69: 1961-1965.
172. Hofhuis A, et al. 2011. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol. Infect. 139:530-538.
173. Hofman P, et al. 1993. Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol. Res. Pract. 189:894-901.
174. Holliman RE, Johnson J, Burke M, Adams S, Pepper JR. 1990. Falsenegative dye-test findings in a case of fatal toxoplasmosis associated with cardiac transplantation. J. Infect. 21:185-189.
175. Homan WL, Vercammen M, De Braekeleer J, Verschueren H. 2000. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int. J. Parasitol. 30:69-75.
176. Hotez PJ. 2008. Neglected infections of poverty in the United States of America. PLoS Negl. Trop. Dis. 2:e256.
177. Howe DK, Sibley LD. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1561-1566.
178. Hutchison WM, Dunachie JF, Siim JC, Work K. 1969. Life cycle of Toxoplasma gondii. Br. Med. J. iv:806.
179. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
180. Jokelainen P, Isomursu M, Nareaho A, Oksanen A. 2011. Natural Toxoplasma gondii infections in European brown hares and mountain hares in Finland: proportional mortality rate, antibody prevalence, and genetic characterization. J. Wildl. Dis. 47:154-163.
181. Jones JL, et al. 2009. Risk factors for Toxoplasma gondii infection in the United States. Clin. Infect. Dis. 49:878-884.
182. Jones JL, Dubey JP. 2010. Waterborne toxoplasmosis-recent developments. Exp. Parasitol. 124:10-25.
183. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. 2007. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am. J. Trop. Med. Hyg. 77:405-410.
184. Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM. 2008. Toxoplasma gondii and Toxocara spp. co-infection. Am. J. Trop. Med. Hyg. 78:35-39.
185. Jones JL, Sehgal M, Maguire JH. 2002. Toxoplasmosis-associated deaths among human immunodeficiency virus-infected persons in the United States, 1992-1998. Clin. Infect. Dis. 34:1161.
186. Kang YA, et al. 2007. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132:959-965.
187. Kapperud G, et al. 1996. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am. J. Epidemiol. 144:405-412.
188. Khan A, et al. 2011. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int. J. Parasitol. 41:645-655.
189. Khan A, et al. 2007. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc. Natl. Acad. Sci. U. S. A. 104:14872-14877.
190. Khan A, et al. 2006. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 12:942-949.
191. Khoshnood B, De Vigan C, Goffinet F, Leroy V. 2007. Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Prenat. Diagn. 27:395-403.
192. Kieffer F, et al. 2008. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr. Infect. Dis. J. 27:27-32.
193. Kijlstra A, Jongert E. 2009. Toxoplasma-safe meat: close to reality? Trends Parasitol. 25:18-22.
194. Kniel KE, et al. 2002. Examination of attachment and survival of Toxoplasma gondii oocysts on raspberries and blueberries. J. Parasitol. 88: 790-793.
195. Kodjikian L, et al. 2004. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr. Infect. Dis. J. 23:272-274.
196. Kotresha D, Noordin R. 2010. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS 118:529-542.
197. Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF. 2002. Ocular toxoplasmosis after the fifth decade. Am. J. Ophthalmol. 133: 506-515.
198. Lachaud L, et al. 2009. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn. Microbiol. Infect. Dis. 64:267-274.
199. Laliberte J, Carruthers VB. 2008. Host cell manipulation by the human pathogen Toxoplasma gondii. Cell. Mol. Life Sci. 65:1900-1915.
200. Lambert H, Barragan A. 2010. Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Cell. Microbiol. 12:292-300.
201. Lamoril J, et al. 1996. Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J. Clin. Pathol. 49:89-92.
202. Lappalainen M, et al. 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 167:691-697.
203. Laurans C, et al. 2002. Necessity of postpartum serologic screening for congenital toxoplasmosis in women who are seronegative at the end of pregnancy. Presse Med. 31:1266-1267. (In French.)
204. Lefevre-Pettazzoni M, et al. 2007. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin. Vaccine Immunol. 14:239-243.
205. Lehmann T, et al. 2004. Variation in the structure of Toxoplasma gondii and the roles of selfing, drift, and epistatic selection in maintaining linkage disequilibria. Infect. Genet. Evol. 4:107-114.
206. Liesenfeld O. 2002. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J. Infect. Dis. 185(Suppl 1):S96-S101.
207. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. 2001. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J. Infect. Dis. 183:1248-1253.
208. Lindsay DS, Collins MV, Holliman D, Flick GJ, Dubey JP. 2006. Effects of high-pressure processing on Toxoplasma gondii tissue cysts in ground pork. J. Parasitol. 92:195-196.
209. Lindsay DS, Dubey JP. 2009. Long-term survival of Toxoplasma gondii sporulated oocysts in seawater. J. Parasitol. 95:1019-1020.
210. Lindsay DS, Dubey JP. 2011. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 138:1829-1831.
211. Lindsay DS, Dubey JP. 2007. Toxoplasmosis in wild and domestic animals, p 133-152. In Weiss LM, Kim K (ed), Toxoplasma gondii: the model apicomplexan. Perspectives and methods. Academic Press, London, United Kingdom.
212. Liu Q, et al. 2009. Toxoplasma gondii infection in pregnant women in China. Trans. R. Soc. Trop. Med. Hyg. 103:162-166.
213. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. 1983. Primary and reactivated Toxoplasma infection in patients with cardiac transplants.Clinical spectrum and problems in diagnosis in a defined population. Ann. Intern. Med. 99:27-31.
214. Luft BJ, Remington JS. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
215. Mai K, et al. 2009. Oocyst wall formation and composition in coccidian parasites. Mem. Inst. Oswaldo Cruz 104:281-289.
216. Martina MN, et al. 2011. Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review. Transpl. Int. 24:e6-e12.
217. Martino R, et al. 2005. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin. Infect. Dis. 40:67-78.
218. Marty P, Le Fichoux Y, Deville A, Forest H. 1991. Congenital toxoplasmosis and preconceptional maternal ganglionic toxoplasmosis. Presse Med. 20:387. (In French.)
219. Mason JC, et al. 1987. Toxoplasmosis in two renal transplant recipients from a single donor. Transplantation 44:588-591.
220. Maubon D, Ajzenberg D, Brenier-Pinchart MP, Darde ML, Pelloux H. 2008. What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol. 24:299-303.
221. Mayes JT, O'Connor BJ, Avery R, Castellani W, Carey W. 1995. Transmission of Toxoplasma gondii infection by liver transplantation. Clin. Infect. Dis. 21:511-515.
222. McAuley J, et al. 1994. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin. Infect. Dis. 18:38-72.
223. McLeod R, et al. 2006. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin. Infect. Dis. 42:1383-1394.
224. Mercier A, et al. 2011. Human impact on genetic diversity of Toxoplasma gondii: example of the anthropized environment from French Guiana. Infect. Genet. Evol. 11:1378-1387.
225. Mercier A, et al. 2010. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl. Trop. Dis. 4:e876.
226. Mercier C, Adjogble KD, Daubener W, Delauw MF. 2005. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites? Int. J. Parasitol. 35:829-849.
227. Meroni V, et al. 2009. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin. Vaccine Immunol. 16:1517-1520.
228. Michaels MG, Wald ER, Fricker FJ, del Nido PJ, Armitage J. 1992. Toxoplasmosis in pediatric recipients of heart transplants. Clin. Infect. Dis. 14:847-851.
229. Miller CM, Boulter NR, Ikin RJ, Smith NC. 2009. The immunobiology of the innate response to Toxoplasma gondii. Int. J. Parasitol. 39:23-39.
230. Miller MA, et al. 2008. Type X Toxoplasma gondii in a wild mussel and terrestrial carnivores from coastal California: new linkages between terrestrial mammals, runoff and toxoplasmosis of sea otters. Int. J. Parasitol. 38:1319-1328.
231. Montoya JG, et al. 2001. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin. Infect. Dis. 33:629-640.
232. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet 363:1965-1976.
233. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. 1999. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 106:1554-1563.
234. Montoya JG, Remington JS. 1996. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin. Infect. Dis. 23:277-282.
235. Mosser DM. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73:209-212.
236. Munoz P, et al. 2003. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin. Infect. Dis. 36:932-933.
237. Naessens A, et al. 1999. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J. Pediatr. 135:714-719.
238. Nagington J, Martin AL. 1983. Toxoplasmosis and heart transplantation. Lancet ii:679.
239. Nascimento FS, Suzuki LA, Rossi CL. 2008. Assessment of the value of detecting specific IgA antibodies for the diagnosis of a recently acquired primary Toxoplasma infection. Prenat. Diagn. 28:749-752.
240. Neto EC, et al. 2000. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int. J. Epidemiol. 29:941-947.
241. Nicolle C, Manceaux L. 1908. Sur une infection a corps de Leishman (ou organismes voisins) du gondi. C. R. Hebd. Seances Acad. Sci. 147:763-766.
242. Nogui FL, Mattas S, Turcato Júnior G, Lewi DS. 2009. Neurotoxoplasmosis diagnosis for HIV-1 patients by real-time PCR of cerebrospinal fluid. Braz. J. Infect. Dis. 13:18-23.
243. Novati R, et al. 1994. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 8:1691-1694.
244. Opsteegh M, et al. 2010. Direct detection and genotyping of Toxoplasma gondii in meat samples using magnetic capture and PCR. Int. J. Food Microbiol. 139:193-201.
245. Opsteegh M, et al. 2011. Low predictive value of seroprevalence of Toxoplasma gondii in cattle for detection of parasite DNA. Int. J. Parasitol. 41:343-354.
246. Orr KE, et al. 1994. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J. Infect. 29:249-253.
247. Palanisamy M, Madhavan B, Balasundaram MB, Andavar R, Venkatapathy N. 2006. Outbreak of ocular toxoplasmosis in Coimbatore, India. Indian J. Ophthalmol. 54:129-131.
248. Pappas G, Roussos N, Falagas ME. 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39:1385-1394.
249. Parmley SF, Goebel FD, Remington JS. 1992. Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by polymerase chain reaction. J. Clin. Microbiol. 30:3000-3002.
250. Patrat-Delon S, et al. 2010. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J. Clin. Microbiol. 48:2541-2545.
251. Paugam A, et al. 1995. Detection of Toxoplasma gondii parasitemia by polymerase chain reaction in perorally infected mice. Parasite 2:181-184.
252. Pelloux H, et al. 1998. A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol. Lett. 165:231-237.
253. Pena HF, Gennari SM, Dubey JP, Su C. 2008. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int. J. Parasitol. 38: 561-569.
254. Pena HF, et al. 2011. Isolation and genetic characterisation of Toxoplasma gondii from a red-handed howler monkey (Alouatta belzebul), a jaguarundi (Puma yagouaroundi), and a black-eared opossum (Didelphis aurita) from Brazil. Vet. Parasitol. 175:377-381.
255. Petersen E, et al. 2005. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondiispecific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43:1570-1574.
256. Pfaff AW, et al. 2007. Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma. Parasitology 134: 1895-1902.
257. Pfefferkorn ER. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 81:908-912.
258. Phan L, et al. 2008. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am. J. Ophthalmol. 146:375-384.
259. Pietkiewicz H, et al. 2007. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulinGavidity test for the serodiagnosis of toxoplasmosis. Parasitol. Res. 100:333-337.
260. Pinon JM, et al. 1996. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J. Clin. Microbiol. 34:579-583.
261. Pinon JM, et al. 2001. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 39:2267-2271.
262. Podzamczer D, et al. 2000. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 19:89-95.
263. Pomares C, et al. 2011. Toxoplasmosis and horse meat, France. Emerg. Infect. Dis. 17:1327-1328.
264. Prestrud KW, et al. 2008. Direct high-resolution genotyping of Toxoplasma gondii in arctic foxes (Vulpes lagopus) in the remote arctic Svalbard archipelago reveals widespread clonal type II lineage. Vet. Parasitol. 158:121-128.
265. Putignani L, et al. 2011. Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG). Exp. Parasitol. 127:409-417.
266. Rabaud C, et al. 1994. Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey. Medicine (Baltimore) 73:306-314.
267. Rabaud C, et al. 1996. Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey. Clin. Infect. Dis. 23:1249-1254.
268. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. 2011. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc. Natl. Acad. Sci. U. S. A. 108:9625-9630.
269. Remington JS. 1969. The present status of the IgM fluorescent antibody technique in the diagnosis of congenital toxoplasmosis. J. Pediatr. 75: 1116-1124.
270. Remington JS, Araujo FG, Desmonts G. 1985. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J. Infect. Dis. 152:1020-1024.
271. Remington JS, McLeod R, Thulliez P, Desmonts G. 2001. Toxoplasmosis, p 205-346. In Remington JS, Klein J (ed), Infectious diseases of the fetus and newborn infant, 5th ed. WB Saunders, Philadelphia, PA.
272. Renoult E, et al. 1997. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin. Infect. Dis. 24:625-634.
273. Rilling V, Dietz K, Krczal D, Knotek F, Enders G. 2003. Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 22:174-180.
274. Robben PM, et al. 2004. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 172:3686-3694.
275. Robert F, et al. 1996. Retrospective evaluation of the detection of Toxoplasma gondii by polymerase chain reaction in AIDS patients. Presse Med. 25:541-545. (In French.)
276. Robert-Gangneux F, Commerce V, Tourte-Schaefer C, Dupouy- Camet J. 1999. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 18: 648-654.
277. Robert-Gangneux F, et al. 2010. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 29:33-38.
278. Robert-Gangneux F, et al. 2011. High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clin. Immunol. 138:129-134.
279. Robert-Gangneux F, et al. 1999. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J. Clin. Microbiol. 37:2893-2898.
280. Robert-Gangneux F, Yera H, D'Herve D, Guiguen C. 2009. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection. Pediatr. Infect. Dis. J. 28:660-661.
281. Robert-Gangneux F, et al. 2004. Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis. Eur. J. Clin. Microbiol. Infect. Dis. 23:34-38.
282. Roberts F, et al. 2001. Histopathological features of ocular toxoplasmosis in the fetus and infant. Arch. Ophthalmol. 119:51-58.
283. Roemer E, et al. 2001. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin. Infect. Dis. 32:E1-E8.
284. Rogers NM, et al. 2008. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transpl. Infect. Dis. 10:71-74.
285. Romand S, et al. 2004. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol. 190:797-802.
286. Romand S, et al. 2001. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet. Gynecol. 97:296-300.
287. Roos DS, et al. 1999. Origin, targeting, and function of the apicomplexan plastid. Curr. Opin. Microbiol. 2:426-432.
288. Rose AG, Uys CJ, Novitsky D, Cooper DK, Barnard CN. 1983. Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantation. Arch. Pathol. Lab. Med. 107:368-373.
289. Roser D, Nielsen HV, Petersen E, Saugmann-Jensen P, Norgaard- Pedersen B. 2010. Congenital toxoplasmosis-a report on the Danish neonatal screening programme 1999-2007. J. Inherit. Metab. Dis. 33: S241-S247.
290. Ryning FW, McLeod R, Maddox JC, Hunt S, Remington JS. 1979. Probable transmission of Toxoplasma gondii by organ transplantation. Ann. Intern. Med. 90:47-49.
291. Saeij JP, Boyle JP, Boothroyd JC. 2005. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 21:476-481.
292. Saeij JP, et al. 2006. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780-1783.
293. Saeij JP, et al. 2007. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445:324-327.
294. Salt A, et al. 1990. Viral and Toxoplasma gondii infections in children after liver transplantation. J. Clin. Pathol. 43:63-67.
295. Sanchez Mejia A, Debrunner M, Cox E, Caldwell R. 2011. Acquired toxoplasmosis after orthotopic heart transplantation in a sulfonamideallergic patient. Pediatr. Cardiol. 32:91-93.
296. Sarchi E, et al. 2007. Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants. New Microbiol. 30:299-302.
297. Savva D, Morris JC, Johnson JD, Holliman RE. 1990. Polymerase chain reaction for detection of Toxoplasma gondii. J. Med. Microbiol. 32:25-31.
298. Schmidt DR, et al. 2006. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch. Dis. Child. 91:661-665.
299. Schoondermark-Van de Ven E, et al. 1993. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin. Infect. Dis. 16:661-666.
300. Schurmann D, et al. 2002. Effectiveness of twice-weekly pyrimethaminesulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 21:353-361.
301. Schwartzman J, et al. 1948. Congenital toxoplasmosis. J. Pediatr. 33:66-73.
302. Shapiro K, et al. 2010. Detection of Toxoplasma gondii oocysts and surrogate microspheres in water using ultrafiltration and capsule filtration. Water Res. 44:893-903.
303. Sibley LD. 2010. How apicomplexan parasites move in and out of cells. Curr. Opin. Biotechnol. 21:592-598.
304. Sibley LD, Ajioka JW. 2008. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu. Rev. Microbiol. 62:329-351.
305. Sibley LD, Boothroyd JC. 1992. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82-85.
306. Sickinger E, et al. 2008. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagn. Microbiol. Infect. Dis. 62:235-244.
307. Silveira C, et al. 2011. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br. J. Ophthalmol. 95: 396-400.
308. Smith DD, Frenkel JK. 1995. Prevalence of antibodies to Toxoplasma gondii in wild mammals of Missouri and east central Kansas: biologic and ecologic considerations of transmission. J. Wildl. Dis. 31:15-21.
309. Sordet F, Aumjaud Y, Fessi H, Derouin F. 1998. Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis. Parasite 5:223-229.
310. Sotiriadou I, Karanis P. 2008. Evaluation of loop-mediated isothermal amplification for detection of Toxoplasma gondii in water samples and comparative findings by polymerase chain reaction and immunofluorescence test (IFT). Diagn. Microbiol. Infect. Dis. 62:357-365.
311. Sroka J, et al. 2010. The occurrence of Toxoplasma gondii infection in people and animals from rural environment of Lublin region-estimate of potential role of water as a source of infection. Ann. Agric. Environ. Med. 17:125-132.
312. Sterkers Y, et al. 2010. Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens. J. Clin. Microbiol. 48:3216-3222.
313. Stricker R, Sitavanc R, Liassine N, de Marval F. 2009. Toxoplasmosis during pregnancy and infancy. Swiss Med. Wkly. 139:643-644.
314. Su C, et al. 2003. Recent expansion of Toxoplasma through enhanced oral transmission. Science 299:414-416.
315. Su C, Zhang X, Dubey JP. 2006. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int. J. Parasitol. 36:841-848.
316. Talabani H, et al. 2009. Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J. Clin. Microbiol. 47:2131-2135.
317. Taylor S, et al. 2006. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776-1780.
318. Tenter AM, Heckeroth AR, Weiss LM. 2000. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30:1217-1258.
319. Thalib L, et al. 2005. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 112:567-574.
320. Thiebaut R, Leproust S, Chene G, Gilbert R. 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369:115-122.
321. Thulliez P. 2001. Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int. J. Epidemiol. 30:1315-1316.
322. Tissot-Dupont D, et al. 2003. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 22:122-125.
323. Turunen HJ, Leinikki PO, Saari KM. 1983. Demonstration of intraocular synthesis of immunoglobulin G Toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay. J. Clin. Microbiol. 17:988-992.
324. Unno A, et al. 2008. Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow. Parasitol. Int. 57:515-518.
325. Vaessen N, Verweij JJ, Spijkerman IJ, van Hoek B, van Lieshout L. 2007. Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCR. Neth. J. Med. 65:222-223.
326. Vallochi AL, et al. 2005. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am. J. Ophthalmol. 139:350-351.
327. Vasconcelos-Santos DV, et al. 2009. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 116:2199.e1-2205.e1.
328. Velmurugan GV, Dubey JP, Su C. 2008. Genotyping studies of Toxoplasma gondii isolates from Africa revealed that the archetypal clonal lineages predominate as in North America and Europe. Vet. Parasitol. 155:314-318.
329. Villard O, et al. 2003. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J. Clin. Microbiol. 41:3537-3541.
330. Villena I, et al. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 15(25): pii_19600. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19600.
331. Villena I, et al. 2004. Evaluation of a strategy for Toxoplasma gondii oocyst detection in water. Appl. Environ. Microbiol. 70:4035-4039.
332. Vutova P, et al. 2007. Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Cell. Microbiol. 9:1556-1570.
333. Waap H, Vilares A, Rebelo E, Gomes S, Angelo H. 2008. Epidemiological and genetic characterization of Toxoplasma gondii in urban pigeons from the area of Lisbon (Portugal). Vet. Parasitol. 157:306-309.
334. Wallon M, et al. 2010. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet. Gynecol. 115:727-733.
335. Wallon M, et al. 2004. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567-1572.
336. Wallon M, Liou C, Garner P, Peyron F. 1999. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 318:1511-1514.
337. Weiss LM, Kim K (ed). 2007. Toxoplasma gondii: the model apicomplexan. Perspectives and methods. Academic Press, London, United Kingdom.
338. Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 39:895-901.
339. Wendte JM, et al. 2010. Self-mating in the definitive host potentiates clonal outbreaks of the apicomplexan parasites Sarcocystis neurona and Toxoplasma gondii. PLoS Genet. 6:e1001261.
340. Westeneng AC, Rothova A, de Boer JH, de Groot-Mijnes JD. 2007. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am. J. Ophthalmol. 144:781-785.
341. Wreghitt TG, et al. 1989. Toxoplasmosis in heart and heart and lung transplant recipients. J. Clin. Pathol. 42:194-199.
342. Yera H, et al. 2009. Multicenter comparative evaluation of five commercial methods for Toxoplasma DNA extraction from amniotic fluid. J. Clin. Microbiol. 47:3881-3886.
343. Zhou P, et al. 2010. Genetic characterization of Toxoplasma gondii isolates from pigs in China. J. Parasitol. 96:1027-1029.